Scorpion Therapeutics

Drug Discovery

Scorpion Therapeutics is a private drug discovery company. It has raised $150 million across 3 recorded rounds; the latest was a $150 million Series C in Jul 2024.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$150.0M
Last round
Later Stage VC (Series C)
Jul 2024
How much has Scorpion Therapeutics raised?
$150.0Macross 3 recorded rounds · Apr 2020 – Jul 2024

Most recently, Scorpion Therapeutics raised $150.0M in its Later Stage VC (Series C) (Jul 2024).

Free account
More of Scorpion Therapeutics with a free account
  • ·Watch Scorpion Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Scorpion Therapeutics round by round

3 rounds
Jul 2024Later Stage VC (Series C)$150.0M▮
+ 1 more investors · free account
Nov 2020Later Stage VC$147.0MSEC filing▮
22 investors participated
Apr 2020Early Stage VC$24.7MSEC filing▮
11 investors participated

How much has Scorpion Therapeutics raised?

Scorpion Therapeutics has raised $150 million across 3 recorded rounds since 2020. The largest was a $24.7 million early-stage round in Apr 2020; the most recent was a $150 million Series C in Jul 2024.

Scorpion Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently in Jul 2024 ($126 million sold to 38 investors).

Frequently asked about Scorpion Therapeutics

How much has Scorpion Therapeutics raised?
Scorpion Therapeutics has raised $150.0M in total across 3 recorded funding rounds.
When was Scorpion Therapeutics's last funding round?
Scorpion Therapeutics's most recent recorded round was Later Stage VC (Series C) in Jul 2024, raising $150.0M.